NSTLShenzhenPeople’s Republic of ChinaAs iaArtificial IntelligenceDiabetic AngiopathiesDiabetic RetinopathyEmergi ng TechnologiesEye Diseases and ConditionsHealth and MedicineMachine Learn ingNutritional and Metabolic Diseases and ConditionsOphthalmologyRetinal D iseases and ConditionsRetinopathyVascular Diseases and Conditions
2024
